Rationale for sequential extracorporeal therapy (SET) in sepsis

• Published in: Critical care (London, England) England), 2023-02, Vol.27 (1), p.50-50, Article 50
• Main Authors: Ronco, Claudio, Chawla, Lakhmir, Husain-Syed, Faeq, Kellum, John A
• Format: Article
• Language: English
• Subjects: Adsorption; Antibiotics; Blood oxygenation, Extracorporeal; Care and treatment; Coronaviruses; COVID-19; Critical care; Cytokines; Development and progression; Diagnosis; Drug resistance; Endotoxin; Endotoxins; Evaluation; Extracorporeal Membrane Oxygenation; Extracorporeal therapies; Gram-positive bacteria; Hemoperfusion - methods; Humans; Methods; Mortality; Pathogens; Polymyxin B - therapeutic use; Proteins; Review; Sepsis; Sepsis - therapy; Septic shock; Severe acute respiratory syndrome coronavirus 2; Shock, Septic - therapy; Streptococcus infections; Viruses
• ISSN: 1364-8535; 1466-609X; 1364-8535; 1366-609X
• DOI: 10.1186/s13054-023-04310-2

Sepsis and septic shock remain drivers for morbidity and mortality in critical illness. The clinical picture of patients presenting with these syndromes evolves rapidly and may be characterised by: (a) microbial host invasion, (b) establishment of an infection focus, (c) opsonisation of bacterial products (e.g. lipopolysaccharide), (d) recognition of pathogens resulting in an immune response, (e) cellular and humoral effects of circulating pathogen and pathogen products, (f) immunodysregulation and endocrine effects of cytokines, (g) endothelial and organ damage, and (h) organ crosstalk and multiple organ dysfunction. Each step may be a potential target for a specific therapeutic approach. At various stages, extracorporeal therapies may target circulating molecules for removal. In sequence, we could consider: (a) pathogen removal from the circulation with affinity binders and cartridges (specific), (b) circulating endotoxin removal by haemoperfusion with polymyxin B adsorbers (specific), (c) cytokine removal by haemoperfusion with sorbent cartridges or adsorbing membranes (non-specific), (d) extracorporeal organ support with different techniques for respiratory and cardiac support (CO removal or extracorporeal membrane oxygenation), and renal support (haemofiltration, haemodialysis, or ultrafiltration). The sequence of events and the use of different techniques at different points for specific targets will likely require trials with endpoints other than mortality. Instead, the primary objectives should be to achieve the desired action by using extracorporeal therapy at a specific point.